Peptides for Sleep

The distinction matters. Sedating yourself to sleep with benzodiazepines, Z-drugs, or antihistamines produces unconsciousness but doesn't reliably produce the deep slow-wave sleep and REM architecture associated with restorative rest. The peptides in this guide work through different mechanisms, modulating delta wave activity, restoring melatonin production, amplifying the natural growth hormone pulse that occurs in early slow-wave sleep. They're not faster ways to fall asleep. They're attempts to improve what happens while you're sleeping.

The sleep architecture distinction

Understanding why some compounds are more relevant than others requires a brief orientation to sleep architecture. Restorative sleep has two components that matter most: slow-wave sleep (SWS), also called deep sleep or Stage 3 NREM, where physical repair, immune function, and memory consolidation occur, and where the body's largest growth hormone pulse is released; and REM sleep, where emotional processing and cognitive integration happen. Most conventional sleep aids suppress REM and often reduce SWS. The peptides discussed here are being studied for the opposite effect: improving SWS without REM suppression.

The evidence-ranked compounds

1. MK-677 (Ibutamoren), strongest human evidence for sleep effects

MK-677 is technically not a peptide, it's a small molecule that mimics ghrelin's action on the GHS-R receptor. But it belongs in this guide because it's the oral option with the most human trial data specifically on sleep architecture. Five peer-reviewed randomised controlled trials confirm 40–60% IGF-1 elevation from oral dosing. The sleep data comes from a controlled trial that used polysomnography to measure sleep architecture: MK-677 significantly increased slow-wave sleep duration in healthy young adults and elderly subjects, consistent with its known mechanism of amplifying GH release during sleep.

The practical advantage: it's oral, taken at bedtime, and produces sleep effects alongside body composition benefits. The practical drawback: appetite stimulation is significant, MK-677's ghrelin-mimicking mechanism increases hunger, which can be counterproductive for people eating in caloric deficit.

2. Epithalon, circadian regulation and melatonin restoration

Epithalon's sleep effects come through its action on the pineal gland. The pineal gland produces melatonin, the hormone that regulates circadian timing and signals the brain to initiate sleep. Melatonin production declines significantly with age, partly due to pineal gland calcification. Epithalon restores pineal gland secretory function, producing endogenous melatonin at physiologically appropriate times rather than replacing it with exogenous supplementation.

The distinction matters: exogenous melatonin at standard supplement doses (1–10mg) produces a pharmacological signal that can desensitise melatonin receptors with chronic use and doesn't address the underlying pineal decline. Epithalon works upstream, supporting the gland's own production capacity. Users consistently report improved sleep onset and circadian entrainment, particularly useful for people with irregular sleep patterns, shift work history, or age-related circadian disruption. The standard cycle is 10 consecutive days, repeated 2–3 times per year.

3. DSIP (Delta Sleep-Inducing Peptide), named for sleep, evidence is modest

DSIP is the peptide most specifically associated with sleep, it was isolated from rabbit cerebral venous blood during induced deep sleep and named for its early observation that it increased delta wave activity on EEG. Despite its compelling name and origin story, the human evidence base is limited. The largest controlled human study enrolled 14 chronic insomniacs in a 1992 double-blind trial, results showed improved delta-wave sleep without REM suppression, a meaningful finding, but from a very small dataset.

DSIP has accumulated over 150 PubMed citations and has been removed from the FDA's Category 2 restricted list as of April 2026, with PCAC review scheduled for July 24. The mechanistic rationale is solid: DSIP modulates several neurotransmitter systems involved in sleep regulation including noradrenaline and serotonin, and may stimulate growth hormone-releasing hormone, which contributes to slow-wave sleep. Protocol: 100–300 mcg subcutaneous or intranasal, 60–90 minutes before bed.

4. Ipamorelin + CJC-1295, the GH pulse amplifier

Growth hormone secretion is deeply intertwined with sleep architecture. The body's largest GH pulse occurs in the first 90 minutes of slow-wave sleep. This pulse drives tissue repair, protein synthesis, fat mobilisation, and immune function overnight. GH secretion declines significantly with age, the nocturnal pulse diminishes in both amplitude and frequency, contributing to reduced overnight repair capacity and worsening sleep quality.

The CJC-1295/Ipamorelin stack timed before bed amplifies the natural nocturnal GH pulse rather than creating an artificial one. The dual receptor mechanism (GHRH + ghrelin receptor) produces a synergistic GH release that appears within the physiological range, maintained by the pituitary's own somatostatin feedback rather than bypassing it. Improved sleep quality is the most consistently reported early effect of this stack, typically appearing within the first 1–2 weeks. Specific subjective reports: deeper sleep, more vivid dreaming (a REM indicator), and better subjective recovery.

5. Selank, for anxiety-driven sleep disruption

Selank doesn't directly improve sleep architecture, it addresses the anxiety and arousal that prevent sleep onset. Its GABAergic modulation and enkephalin effects reduce the cortisol-driven 3am awakening pattern without the sedation, dependency, or morning grogginess of benzodiazepines. For people whose sleep problems are driven by anxiety, racing thoughts, or the perimenopausal cortisol surge pattern, Selank addresses the root cause rather than forcing unconsciousness. Nasal spray, 250mcg, 30–60 minutes before bed.

The stack for sleep, what's actually reasonable

The DSIP + Epithalon combination is the most specifically targeted sleep stack, DSIP addresses delta wave activity, Epithalon addresses melatonin and circadian regulation. Independent Moscow State University research found their combination produced 40–55% increases in slow-wave sleep duration versus baseline in polysomnography studies. That's a significant finding, though from a single research group.

For most people, the practical entry point is one of two options: MK-677 at bedtime if oral convenience is the priority and body composition is a concurrent goal; or the CJC-1295/Ipamorelin stack at bedtime if injectable protocols are acceptable and GH axis support is the broader goal. Both produce real sleep improvements through the GH-sleep connection, with the most human trial support of any sleep peptide approach.